This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
CryoPort (CYRX) delivered earnings and revenue surprises of 10.81% and 0.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Avis Budget Group (CAR) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Avis Budget (CAR) delivered earnings and revenue surprises of -84.23% and 4.01%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Hertz Global Holdings, Inc. (HTZ) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Hertz Global (HTZ) delivered earnings and revenue surprises of -19.01% and 4.96%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
CryoPort (CYRX) Moves 26.7% Higher: Will This Strength Last?
by Zacks Equity Research
CryoPort (CYRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CryoPort (CYRX) Loses -43.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for CryoPort (CYRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Earnings Preview: CryoPort, Inc. (CYRX) Q1 Earnings Expected to Decline
by Zacks Equity Research
CryoPort (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -59.38% and 1.74%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CryoPort, Inc. (CYRX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy CryoPort, Inc. (CYRX) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
Hub Group (HUBG) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Hub Group (HUBG) delivered earnings and revenue surprises of 3.85% and 0.68%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Expeditors International (EXPD) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Expeditors International (EXPD) delivered earnings and revenue surprises of -7.20% and 5.75%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CryoPort, Inc. (CYRX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 21st
by Zacks Equity Research
ALPMY, CYRX and DRCT have been added to the Zacks Rank #5 (Strong Sell) List on August 21, 2023.
CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -68% and 0.14%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Daseke (DSKE) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Daseke (DSKE) delivered earnings and revenue surprises of -70.83% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Hub Group (HUBG) Beats Q2 Earnings Estimates
by Zacks Equity Research
Hub Group (HUBG) delivered earnings and revenue surprises of 2.13% and 6.91%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of 11.11% and 1.39%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Trinity Industries (TRN) Misses Q1 Earnings Estimates
by Zacks Equity Research
Trinity Industries (TRN) delivered earnings and revenue surprises of -78.13% and 10.64%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Will CryoPort, Inc. (CYRX) Report Negative Q1 Earnings? What You Should Know
by Zacks Equity Research
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -14.29% and 4.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
C.H. Robinson Worldwide (CHRW) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
C.H. Robinson (CHRW) delivered earnings and revenue surprises of -23.70% and 9.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Syneos Health (SYNH) Signs New Partnership With Cryoport
by Zacks Equity Research
Syneos Health (SYNH) inks a partnership with Cryoport to deliver seamless integration and insights for key services for cell and gene trial operations to biopharmaceutical customers.
CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -15.38% and 13.89%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Schneider National (SNDR) Q3 Earnings Top Estimates
by Zacks Equity Research
Schneider National (SNDR) delivered earnings and revenue surprises of 4.48% and 2.90%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) Stock Jumps 10.5%: Will It Continue to Soar?
by Zacks Equity Research
CryoPort, Inc. (CYRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.